Macrolides: Difference between revisions
(Text replacement - "PNA" to "pneumonia") |
ClaireLewis (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
*Erythromycin, Clarithromycin, Azithromycin | *[[Erythromycin]], [[Clarithromycin]], [[Azithromycin]] | ||
**Community-acquired pneumonia | **Community-acquired [[pneumonia]] | ||
**Mycoplasma | **[[Mycoplasma]] | ||
**Legionnaires' Disease | **[[Legionella|Legionnaires' Disease]] | ||
**Chlamydia (single dose) | **[[Chlamydia]] (single dose) | ||
**H. Pylori | **[[H. Pylori]] | ||
**Traveler's diarrhea (children and pregnant women) | **[[Traveler's diarrhea]] (children and pregnant women) | ||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
Revision as of 23:03, 22 September 2019
- Erythromycin, Clarithromycin, Azithromycin
- Community-acquired pneumonia
- Mycoplasma
- Legionnaires' Disease
- Chlamydia (single dose)
- H. Pylori
- Traveler's diarrhea (children and pregnant women)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See Also
References
Goodman & Gilman's Pharmacology